EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Modulation of bioenergetic metabolism by PDIA3 inhibition prevents breast cancer cell adhesion to endothelial cells

Marta Stojak, Kamila Wojnar-Lason, Anna Kurpinska, Patrycja Kaczara, Filip A Fedak, Joanna Suraj-Prazmowska, Martyna Stachowicz-Suhs, Joanna Rossowska, Magdalena Milczarek, Ivars Kalviņš, Joanna Wietrzyk, Stefan Chlopicki

Biochemical Pharmacology · 2025

DOI: 10.1016/j.bcp.2025.117344 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2025. Verfasst von Marta Stojak und 11 weiteren Autor:innen. Beteiligte Einrichtung: Jagiellonian University, Jagiellonian Centre for Experimental Therapeutics (JCET), Bobrzynskiego 14, 30-348 Krakow, Poland. Electronic address: marta…. Hauptthemen laut MEDLINE: Protein Disulfide-Isomerases, Energy Metabolism, Breast Neoplasms, Endothelial Cells. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre Poland, Uniwersytet Jagiellonski w Krakowie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Increased expression of protein disulphide isomerase (PDI), particularly PDIA3, is associated with breast cancer cell aggressiveness. However, it has not been explored whether PDIA3 modulates cancer cell phenotypes by altering cancer cell metabolism. Here, we investigated the effects of C-3399, a novel PDIA3 inhibitor, on the adhesion of breast cancer cells to the extracellular matrix (ECM) and pulmonary microvascular endothelial cells (hLMVEC). Additionally, we explored whether the anti-adhesive effect of PDIA3 inhibition by C-3399 could be mediated by changes in cellular bioenergetics. We found that PDIA3 inhibition modifies adhesive interactions of two human breast cancer lines, representing the luminal (MCF-7) and basal (MDA-MB-231) subtypes, to ECM and hLMVEC. We confirmed that the anti-adhesive effect of C-3399 was due to the inhibition of PDIA3, as the effect was lost in cancer cells with silenced PDIA3. MCF-7 and MDA-MB-231 cells displayed distinct metabolic profiles, with higher levels of tricarboxylic acid (TCA) cycle metabolites in MCF-7. Interestingly, the anti-adhesive effect of PDIA3 inhibition was associated with the downregulation of TCA metabolites (malate, fumarate, alpha-ketoglutarate, isocitrate) and increased lactate production, particularly in MCF-7 cells. Treatment with mitochondrial respiration inhibitors phenocopied the anti-adhesive effect in MCF-7 but had weaker effects in MDA-MB-231 cells. Quantification of C-3399 and its major metabolite (C-3399-B) revealed the extracellular metabolism of the active compound. In conclusion, the inhibition of extracellular PDIA3 represents a novel approach to inhibit the mitochondrial bioenergetic metabolism of cancer cells and to limit adhesion of cancer cells to the pulmonary endothelium.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Disulfide-IsomerasesEnergy MetabolismBreast NeoplasmsEndothelial CellsCell AdhesionEnzyme InhibitorsHumansFemaleMCF-7 CellsCell Line, Tumor

Stichwörter der Autor:innen

AdhesionBreast cancer cellsCellular bioenergeticsEndothelial cellsPDIA3

Substanzen

Protein Disulfide-IsomerasesPDIA3 protein, humanEnzyme Inhibitors

Autor:innen und Institutionen

  • Jagiellonian University, Jagiellonian Centre for Experimental Therapeutics (JCET), Bobrzynskiego 14, 30-348 Krakow, Poland. Electronic address: marta.stojak@jcet.eu.
  • Jagiellonian University, Jagiellonian Centre for Experimental Therapeutics (JCET), Bobrzynskiego 14, 30-348 Krakow, Poland; Jagiellonian University Medical College, Chair of Pharmacology, Grzegorzecka 16, 31-531 Krakow,…
  • Jagiellonian University, Jagiellonian Centre for Experimental Therapeutics (JCET), Bobrzynskiego 14, 30-348 Krakow, Poland.
  • Jagiellonian University, Jagiellonian Centre for Experimental Therapeutics (JCET), Bobrzynskiego 14, 30-348 Krakow, Poland; Doctoral School of Exact and Natural Sciences, Jagiellonian University, Lojasiewicza 11, Krakow…
  • Department of Experimental Oncology, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Weigla 12, 53-114 Wroclaw, Poland.
  • Laboratory of Carbofunctional Compounds, Latvian Institute of Organic Synthesis, Riga LV-1006, Latvia.

Förderung

  • National Science Centre Poland
  • Uniwersytet Jagiellonski w Krakowie

Zitieren

APA

Stojak, M., Wojnar-Lason, K., Kurpinska, A., Kaczara, P., Fedak, F. A., Suraj-Prazmowska, J., Stachowicz-Suhs, M., Rossowska, J., Milczarek, M., Kalviņš, I., Wietrzyk, J., & Chlopicki, S. (2025). Modulation of bioenergetic metabolism by PDIA3 inhibition prevents breast cancer cell adhesion to endothelial cells. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2025.117344

Vancouver

Stojak M, Wojnar-Lason K, Kurpinska A, Kaczara P, Fedak FA, Suraj-Prazmowska J, et al. Modulation of bioenergetic metabolism by PDIA3 inhibition prevents breast cancer cell adhesion to endothelial cells. Biochemical Pharmacology. 2025. doi:10.1016/j.bcp.2025.117344

BibTeX
@article{Stojak2025,
  author = {Stojak, Marta and Wojnar-Lason, Kamila and Kurpinska, Anna and Kaczara, Patrycja and Fedak, Filip A and Suraj-Prazmowska, Joanna and Stachowicz-Suhs, Martyna and Rossowska, Joanna and Milczarek, Magdalena and Kalviņš, Ivars and Wietrzyk, Joanna and Chlopicki, Stefan},
  title = {Modulation of bioenergetic metabolism by PDIA3 inhibition prevents breast cancer cell adhesion to endothelial cells},
  journal = {Biochemical Pharmacology},
  year = {2025},
  doi = {10.1016/j.bcp.2025.117344}
}
Kostenlos starten →